COVID-19 has been described as the cause for a proinflammatory and hypercoagulable state that induces thrombotic vascular lesions and, in more severe cases, disseminated intravascular coagulation. Increased values of d-dimers are related to the severity of the disease and are associated with worst prognosis. Intensive care studies reported an increased risk of pulmonary embolism and venous thrombosis diseases in COVID-19 compared with the historical control group even in patients who underwent the low-molecular-weight heparin (LWMH) prophylaxis. Patients with COVID-19 who have a stable clinical condition do not require hospitalisation and are treated at home with symptomatic therapy. LWMH is reserved for those with reduced mobility. In this case report, we describe a COVID-19 patient with pulmonary artery thrombosis treated at home.
Pulmonary artery thrombosis in home patient with a mild COVID-19 disease Tromboza arterei pulmonare la pacient cu boala COVID 19 forma usoara aflat la domiciliu / Graziani A.; Domenicali M.; Zanframundo G.; Palmese F.; Caroli B.; Cataleta P.; Graziani L.. - In: PNEUMOLOGIA. - ISSN 2067-2993. - ELETTRONICO. - 69:2(2020), pp. 103-106. [10.2478/pneum-2020-0012]
Pulmonary artery thrombosis in home patient with a mild COVID-19 disease Tromboza arterei pulmonare la pacient cu boala COVID 19 forma usoara aflat la domiciliu
Domenicali M.Membro del Collaboration Group
;Palmese F.Membro del Collaboration Group
;
2020
Abstract
COVID-19 has been described as the cause for a proinflammatory and hypercoagulable state that induces thrombotic vascular lesions and, in more severe cases, disseminated intravascular coagulation. Increased values of d-dimers are related to the severity of the disease and are associated with worst prognosis. Intensive care studies reported an increased risk of pulmonary embolism and venous thrombosis diseases in COVID-19 compared with the historical control group even in patients who underwent the low-molecular-weight heparin (LWMH) prophylaxis. Patients with COVID-19 who have a stable clinical condition do not require hospitalisation and are treated at home with symptomatic therapy. LWMH is reserved for those with reduced mobility. In this case report, we describe a COVID-19 patient with pulmonary artery thrombosis treated at home.I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
